SpectraCure AB (publ) (FRA:2OK)

Market Cap	3.91M -79.7%
Revenue (ttm)	n/a
Net Income	-4.81M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.1620
Beta	n/a
RSI	32.50
Earnings Date	Feb 20, 2026

About SpectraCure AB

SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2003
• Employees: 13
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2OK

Financial Performance

Financial numbers in SEK